Sponsor or institution
Clinical trials and research at AIO-Studien-gGmbH
As of November 12, 2026, Find a Trial lists 5 clinical trials run by AIO-Studien-gGmbH that are recruiting, in Germany. 1 was first registered in the last 30 days. By phase: Phase 2 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 5Clinical trials
- 1New in 30 days
- 1Country
Newest trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| TACE plus SBRT before liver transplant for hepatocellular carcinoma | — | München | Recruiting | Nov 9, 2026 |
| Tarlatamab in strong-performance-status small-cell lung cancer | Phase 2 | Berlin and 7 other locations | Recruiting | Sep 4, 2026 |
| Platform for studying biomarkers and treatments in head and neck cancer | — | Essen and 1 other locations | Recruiting | Apr 24, 2024 |
| Connecting clinical and genomic data for patients with advanced solid tumors | — | Freiburg im Breisgau, Baden-Wurttemberg and 2 other locations | Recruiting | Jan 27, 2023 |
| Platform for assessing molecular testing and treatment outcomes in lung cancer patients | — | Oldenburg | Recruiting | Dec 4, 2015 |
All recruiting trials (5)
-
TACE plus SBRT before liver transplant for hepatocellular carcinoma
This study tests whether adding SBRT to standard TACE helps liver transplant patients with hepatocellular carcinoma see better outcomes.
-
Tarlatamab in strong-performance-status small-cell lung cancer
This trial tests whether tarlatamab can help people with extensive-stage small-cell lung cancer and poor health (ECOG 2) who have already had prior treatment.
-
Platform for studying biomarkers and treatments in head and neck cancer
This study is trying to gather information on how well different treatments work for people with advanced head and neck cancer to help improve future care.
-
Connecting clinical and genomic data for patients with advanced solid tumors
This study is gathering and analyzing health and genetic information from patients with advanced solid tumors to improve cancer treatment in Germany.
-
Platform for assessing molecular testing and treatment outcomes in lung cancer patients
This study is trying to gather and analyze information about treatments and outcomes for people with lung cancer to improve care and understand their quality of life better.
Quick answers
How many clinical trials run by AIO-Studien-gGmbH are recruiting right now?
5, as of November 12, 2026. 1 of them was first registered in the last 30 days. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
All of them have sites in Germany. Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 2: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.